Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers - Test2 - elhamkhani - TriplyDB

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

http://www.wikidata.org/entity/Q33684243

about

What can we learn about autism from studying fragile X syndrome?Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder Fragile X spectrum disorders Fragile X-associated tremor/ataxia syndrome.Unstable mutations in the FMR1 gene and the phenotypes Fragile X: leading the way for targeted treatments in autism.Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxiety.Climbing the branches of a family tree: diagnosis of fragile X syndrome.FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States Towards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation Carriers Sleep apnea in fragile X premutation carriers with and without FXTAS.Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening Emerging topics in FXTAS.Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.Modulation of the GABAergic pathway for the treatment of fragile X syndrome.Eye movements reveal impaired inhibitory control in adult male fragile X premutation carriers asymptomatic for FXTAS.The fragile X-associated tremor ataxia syndrome (FXTAS) in Indonesia.Fragile X syndrome: an update on developing treatment modalities.Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment.Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.Current research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome.Motor deficits on a ladder rung task in male and female adolescent and adult CGG knock-in mice PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS.Postpartum Depression in Women with the FMR1 Premutation.Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders Mouse models of the fragile x premutation and the fragile X associated tremor/ataxia syndrome.FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses.Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers Assessment of patient and caregiver needs in fragile X-associated tremor/ataxia syndrome by utilizing Q-sort methodology.Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation.Enhanced manual and oral motor reaction time in young adult female fragile X premutation carriers.Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice.FMR1 premutation and full mutation molecular mechanisms related to autism.Psychosis and catatonia in fragile X: Case report and literature review.Maternal Consequences of the Detection of Fragile X Carriers in Newborn Screening Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands.Prevalence of CGG expansions of the FMR1 gene in a US population-based sample.Daily health symptoms of mothers of adolescents and adults with fragile x syndrome and mothers of adolescents and adults with autism spectrum disorder.

P2860

Q24613049-D3405B01-C2ED-4A2C-8C76-414D6429CA4A Q26781265-2FD9FB99-BCB1-4D49-8132-95BD6D7186AE Q26824376-911EDB6F-9413-4439-BFED-80A025B29395 Q26852667-E544E3DA-89F3-4E19-ACF5-64F8A8DB0450 Q26996649-FA7E4860-C5EF-4B3E-8C0E-B03453A5E55B Q30435321-4D87B81D-DB40-49F4-9D0F-9BF596E96EFF Q33629743-12DDE01C-DAAD-4F94-A2DC-FC235AE23278 Q33671154-ED2F6D12-EE30-4266-BBCB-6085FF390811 Q33781086-052901EA-A94B-4F91-B413-8677821B633E Q33863331-7D45AA5E-3DEC-45E1-BE49-521DA93BAD42 Q33943666-4520C377-69D3-4106-8926-B4E59843934F Q34046162-839822E9-973B-45DB-A035-FC34F80062E2 Q34077088-C04B0CA3-880A-4B6F-8F7D-CF6372A3BE3C Q34198650-1FEB3FC2-A22A-4C0C-AB1C-EEF079FEC447 Q34230612-DAF5640E-7F6E-4867-8170-2A3408E76039 Q34231104-2950DF1C-8A0C-4E4B-A29F-214D85F6DCC4 Q34262287-71542DFC-CC28-4C76-B9F5-F3E5AAAF8D10 Q34292108-92F20557-5CB6-445F-BF1B-5869595AC46E Q34329664-42350A15-3A81-452D-8A7A-4E2FD30AA4B2 Q34575595-67D861CF-DBE3-4BAC-801D-F773BD3B4520 Q34977377-6BF583D1-C6BE-490A-B449-DB86EA84536C Q34983498-47B145C3-CC25-44EE-AD69-54661D4A3D50 Q34984624-2CEA646A-67DC-4EF3-A1BB-C81E85D2AFD4 Q35006614-50840B72-2677-4E41-9FB7-4042C3BC1356 Q35006624-18B8ED77-2757-4213-92BA-616A4EBD0801 Q35027822-F737220D-1D91-41E5-B3B3-BADCFDC7BBB1 Q35037764-9D2894BA-EE6A-42BD-8A88-09E5BF20C798 Q35061105-432F8645-682D-482D-ACE6-558CD36EDC85 Q35144045-06674947-3AF2-40E1-9C93-A741D7047D2F Q35248803-CA0E9254-D43C-4587-B90D-B3A0E5C29CEB Q35293962-9188642B-B538-40E1-A460-76FDD6BE13FD Q35317411-46C33A5C-9E7E-4C3A-8290-4F75B1364730 Q35535810-8EBDF16C-FDDF-4960-8FFD-04D2F29544D6 Q35567307-63533E09-A369-4099-B809-5BAC6E4F54FF Q35680720-B5BFE07C-84FF-4BDC-9589-5C1F150B0B57 Q35771116-30D35B80-AD87-4265-AFA1-0D5163A14FAA Q35894764-363B69ED-2C69-4109-8EE1-3B8A130D14E6 Q36031757-788C3643-4956-4AA7-9C86-AF781C3ED64E Q36082674-716C51C2-E381-4DCF-8524-217700A0FDA7 Q36185950-39E7A632-55F7-4D17-B2C8-1B5C4BBD3037

P2860

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

http://www.wikidata.org/entity/Q33684243

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

@ast

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

@en

type

label

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

@ast

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

@en

prefLabel

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

@ast

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

@en

P1433

Q33684243-2A4C685D-26BC-4ABB-A0EB-8DB3AD9EE886

P1476

Q33684243-600D20B8-2191-4D60-AF50-6B8471D90A9E

P2093

Q33684243-05F8FBAE-ADC5-4913-9C31-43148362D999

Q33684243-1F8BB10B-E6FE-4320-B8DD-36CA76BD14C3

Q33684243-37297ECB-E0F1-4FE6-8B3C-FA74B306CCEC

Q33684243-78C23846-F44A-432A-902A-33D9239BF009

Q33684243-ADEE5B53-D6E7-45EA-A9E5-1B15AA485640

Q33684243-BB63076F-A79E-4030-9435-3715CB43F74D

Q33684243-C895EF36-B521-4DFA-9942-3CD88553E465

Q33684243-E51B74C6-DA4D-499A-97E3-53BB7A3CE160

Q33684243-FEE8B3DF-98D7-48F2-8021-1E135A7217DF

P2860

Q33684243-08660A1E-A551-4111-A5D9-85725A78A281

Q33684243-104EA7F0-CFA6-4408-8733-A5D9601154FD

Q33684243-12424272-8204-481D-8449-CA84E279BB78

Q33684243-131B2D31-F9A9-483C-A296-856174F880C0

Q33684243-15B1703E-63F2-4DFA-B3E4-C38950D5B62A

Q33684243-19066FCA-D0F1-4BCF-BAA7-B51A38CFE942

Q33684243-1AC42A5E-D445-4070-8595-523E97AB4E62

Q33684243-1D37B117-5C6C-4538-BAB9-D99AD2B8D96F

Q33684243-23C139B7-CE15-4A26-91D1-E73293BD6A72

Q33684243-2BE6098A-06D0-4758-BB6D-3ECF2DFA6C78

P304

Q33684243-71DA76C6-A066-4900-8D7E-E0E00B61B949

P31

Q33684243-FB3E72C4-C920-4869-AAC9-6B3CA5BA4AD6

P356

Q33684243-D770D307-0AE1-4E79-88D5-180987B8B9CA

P433

Q33684243-B7BBE570-28DC-4BCC-8FD6-DF6CAA9F4ADA

P478

Q33684243-6CF52510-F51F-43A5-85F7-D39B00594506

P50

Q33684243-25C2432B-5B16-4085-A764-550BE2621DA8

P577

Q33684243-7571B3E4-F2B7-442C-9B5C-93F4CE3676B8

P698

Q33684243-BE33362B-8429-4C82-A809-620DCF5E6E37

P932

Q33684243-9EAE1116-0C22-4C0B-AAB6-B8BF7D020A87

P356

JCP.09M05407BLU

P1433

The Journal of Clinical Psychiatry

P1476

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers

@en

P2093

Andreea L Seritan

http://www.w3.org/2001/XMLSchema#string

Danh V Nguyen

http://www.w3.org/2001/XMLSchema#string

David Hessl

http://www.w3.org/2001/XMLSchema#string

E Melina Casillas

http://www.w3.org/2001/XMLSchema#string

Inderjeet Kaur

http://www.w3.org/2001/XMLSchema#string

James A Bourgeois

http://www.w3.org/2001/XMLSchema#string

Jennifer B Cogswell

http://www.w3.org/2001/XMLSchema#string

Randi J Hagerman

http://www.w3.org/2001/XMLSchema#string

Ying Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation

The fragile-X premutation: a maturing perspective.

Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome

Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function

Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles

Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

Aging in individuals with the FMR1 mutation.

P304

175-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4088/JCP.09M05407BLU

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Andrea Schneider

P577

2010-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20816038

http://www.w3.org/2001/XMLSchema#string

P932

4038118

http://www.w3.org/2001/XMLSchema#string